genOway Société anonyme (FRA:JEH)

Germany · Delayed Price · Currency is EUR

2.230

+0.020 (0.90%)

Last updated: Jun 26, 2026, 2:54 PM CET

-32.42% (1Y)

Market Cap	21.30M -34.0%
Revenue (ttm)	28.60M +3.9%
Net Income	927.75K -49.3%
EPS	n/a
Shares Out	n/a
PE Ratio	22.96
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	2.200
Previous Close	2.210
Day's Range	2.200 - 2.230
52-Week Range	2.030 - 3.300
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 1, 2026

About genOway Société anonyme

genOway Société anonyme, a biotechnology company, engages in the development and commercialization of custom genetically modified mouse, rat, and cell line models worldwide. It produces customized mouse models, such as knockout (KO) and knockin (KI) mouse models; customized rat models, including constitutive and conditional KO, point mutation KI, and quick KI rat models; and customized cell lines, such as constitutive and inducible KO, point mutation KI, reporter KI, quick KI, and KI cell lines. The company also offers humanized immune checkpoi... [Read more]

Industry In Vitro and In Vivo Diagnostic Substances

Founded 1999

Employees 157

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol JEH

Financial Performance

In 2025, genOway Société anonyme's revenue was 28.60 million, an increase of 3.88% compared to the previous year's 27.53 million. Earnings were 927,754, a decrease of -49.32%.

Financial Statements